Завершено
Фаза II
Россия
SRT2104; Placebo · Sirtris, a GSK Company
A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects